Elicio Therapeutics, Inc. (ELTX) stock
ELTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.50−0.06 (-3.85%)
Close on Nov 13, 2026Market cap $39.42MP/E –Yield –
Elicio Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Elicio Therapeutics's total debt was $9.64M at Sep 30, 2026. For fiscal 2025 it was $9.41M, down 53.0% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.41M | -53.0% |
| FY2024 | Dec 31, 2024 | $20.03M | – |
| FY2021 | Dec 31, 2021 | $0 | -100.0% |
| FY2020 | Dec 31, 2020 | $635.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $9.64M | -0.9% |
| Q2 FY2026 | Jun 30, 2026 | $9.54M | +2.1% |
| Q1 FY2026 | Mar 31, 2026 | $9.48M | -52.7% |
| Q4 FY2025 | Dec 31, 2025 | $9.41M | – |
| Q3 FY2025 | Sep 30, 2025 | $9.72M | – |
| Q2 FY2025 | Jun 30, 2025 | $9.34M | – |
| Q4 FY2024 | Dec 31, 2024 | $20.03M | – |
| Q4 FY2021 | Dec 31, 2021 | $0 | -100.0% |
| Q3 FY2021 | Sep 30, 2021 | $0 | – |
| Q2 FY2021 | Jun 30, 2021 | $0 | – |
| Q1 FY2021 | Mar 31, 2021 | $0 | – |
| Q4 FY2020 | Dec 31, 2020 | $635.00K | – |
See a number that looks wrong?